FVG-26818-96517
4 vaccinations
4 coded responses
47 check-ins
4 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 31-35
- ZIP prefix
- 618 / IL
- Registered
- 2021-02-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-03
Registered in v-safe
-
2021-02-03
Dose 1 — Moderna
- 2021-02-03
-
2021-02-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Joint pains, Fatigue or tirednessAdult check-in
-
2021-02-05
Survey response — days 1–6 daily, dose 1MedDRA: Chills, Migraine, Ocular hyperaemia, Ophthalmic migraine, Pyrexia — Feeling: Fair · Fever · Chills, Headache, Fatigue or tirednessFree text: Mild Fever and chills overnight. Bloodshot eyes, mild eye- type migraineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
-
2021-03-04
Dose 2 — Moderna
- 2021-03-04
-
2021-03-05
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction — Feeling: Fair · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Mostly overnightMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-06-03
- 2021-09-02
-
2021-10-28
Dose 3 — ModernaCo-administered: Flu
- 2021-10-28
-
2021-10-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-11
- 2021-11-18
- 2021-11-25
- 2021-12-02
- 2021-12-09
- 2022-01-27
- 2022-04-28
-
2022-09-20
Dose 4 — Moderna
- 2022-10-07
- 2022-10-11
- 2022-10-18
-
2022-10-25
Survey response — day 35, dose 4MedDRA: Upper-airway cough syndrome — Feeling: FairFree text: Post nasal drip. Would be very difficult to convince me its related to the vaccine.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-01
Survey response — day 42, dose 4MedDRA: Gastrointestinal disorder, Increased viscosity of upper respiratory secretion, Migraine, Productive cough, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I had a positive covid test on 10_26_22. I mainly had fever, migraine, and GI issues. As it started to resolve i had a lot of congestion and thick mucous ive been hacking up. Im recovering fine, i hope to be better by end of this week. Ty vaccines!MedDRA releases: 2024-11 · check-in free text available
- 2022-12-20
- 2023-03-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-03 | Moderna | |
| 2 | 2021-03-04 | Moderna | |
| 3 | 2021-10-28 | Moderna | Flu |
| 4 | 2022-09-20 | Moderna | No |
Free text
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): Mild Fever and chills overnight. Bloodshot eyes, mild eye- type migraine
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Mostly overnight
Release 12 — day 35, dose 4
Symptoms: Post nasal drip. Would be very difficult to convince me its related to the vaccine.
Release 12 — day 42, dose 4
Symptoms: I had a positive covid test on 10_26_22. I mainly had fever, migraine, and GI issues. As it started to resolve i had a lot of congestion and thick mucous ive been hacking up. Im recovering fine, i hope to be better by end of this week. Ty vaccines! cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Increased viscosity of upper respiratory secretion | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Migraine | ✓ | ✓ | ○ |
| SRO | Ocular hyperaemia | ✓ | ✓ | ✓ |
| SRO | Ophthalmic migraine | ✓ | · | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ○ | ○ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release